The association of amfetamines and cathinones with acute coronary syndrome – a systematic review

References

• O’Gara PT, Kushner FG, Ascheim DD, et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362–e425.
   Web of Science ®Google Scholar
• Ali WM, Zubaid M, Al-Motarreb A, et al. Association of khat chewing with increased risk of stroke and death in patients presenting with acute coronary syndrome. Mayo Clin Proc. 2010;85(11):974–980.
   PubMed Web of Science ®Google Scholar
• Westover AN, Nakonezny PA, Haley RW. Acute myocardial infarction in young adults who abuse amphetamines. Drug Alcohol Depend. 2008;96(1-2):49–56.
   PubMed Web of Science ®Google Scholar
• Hawley LA, Auten JD, Matteucci MJ, et al. Cardiac complications of adult methamphetamine exposures. J Emerg Med. 2013;45(6):821–827.
   PubMed Web of Science ®Google Scholar
• Curran L, Nah G, Marcus GM, et al. Clinical correlates and outcomes of methamphetamine-associated cardiovascular diseases in hospitalized patients in California. J Am Heart Assoc. 2022;11:e023663.
   PubMed Web of Science ®Google Scholar
• McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation. 2008;117(14):1897–1907.
   PubMed Web of Science ®Google Scholar
• Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):e344–e426.
   PubMed Web of Science ®Google Scholar
• Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367.
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the european society of cardiology (ESC). Eur Heart J. 2018;39(2):119–177.
   PubMed Web of Science ®Google Scholar
• Huis In’t Veld MA, Cullen L, Mahler SA, et al. The fast and the furious: low-risk chest pain and the rapid rule-out protocol. West J Emerg Med. 2017;18(3):474–478.
   PubMed Web of Science ®Google Scholar
• World Drug Report 2020. United Nations Publication, Sales No. E.20.XI.6; 2020. Available from: https://wdr.unodc.org/wdr2020/en/index2020.html
   Google Scholar
• Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). Br Med J. 2006;333(7578):1091.
   PubMed Web of Science ®Google Scholar
• Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. J Am Med Assoc. 2000;284(7):835–842.
   PubMed Web of Science ®Google Scholar
• Six AJ, Backus BE, Kelder JC. Chest pain in the emergency room: value of the HEART score. Neth Heart J. 2008;16(6):191–196.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.
   PubMedGoogle Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses: Ottawa Hospital Research Institute; 2015. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Al-Motarreb A, Al-Kebsi M, Al-Adhi B, et al. Khat chewing and acute myocardial infarction. Heart. 2002;87(3):279–280.
   PubMed Web of Science ®Google Scholar
• Al-Motarreb A, Shabana A, El-Menyar A. Epicardial coronary arteries in khat chewers presenting with myocardial infarction. Int J Vasc Med. 2013;2013:857019.
   PubMedGoogle Scholar
• Ahmed AM, Abdulwahab AM, Hesham AF, et al. Clinical presentation, management and outcome of acute coronary syndrome in Yemen: data from Gulf RACE - 2 registry. Heart Views. 2013;14(4):159–164.
   PubMedGoogle Scholar
• Ali WM, Al Habib KF, Al-Motarreb A, et al. Acute coronary syndrome and khat herbal amphetamine use: an observational report. Circulation. 2011;124(24):2681–2689.
   PubMed Web of Science ®Google Scholar
• Al Shehri MA, Youssef AA. Acute myocardial infarction with multiple coronary thromboses in a young addict of amphetamines and benzodiazepines. J Saudi Heart Assoc. 2016;28(3):180–184.
   PubMedGoogle Scholar
• Alghamdi M, Alqahtani B, Alhowti S. Cardiovascular complications among individuals with amphetamine-positive urine drug screening admitted to a tertiary care hospital in Riyadh. J Saudi Heart Assoc. 2016;28(3):129–135.
   PubMedGoogle Scholar
• Bashour TT. Acute myocardial infarction resulting from amphetamine abuse: a spasm-thrombus interplay? Am Heart J. 1994;128(6 Pt 1):1237–1239.
   PubMed Web of Science ®Google Scholar
• Carson P, Oldroyd K, Phadke K. Myocardial infarction due to amphetamine. Br Med J (Clin Res Ed). 1987;294(6586):1525–1526.
   PubMed Web of Science ®Google Scholar
• Chia-Yu Chang J, Peng CZ, How CK, et al. An unusual case of silent acute ST-elevation myocardial infarction following amphetamine use. Pak J Med Sci. 2013;29(4):1059–1061.
   PubMed Web of Science ®Google Scholar
• Huang CN, Wu DJ, Chen KS. Acute myocardial infarction caused by transnasal inhalation of amphetamine. Jpn Heart J. 1993;34(6):815–818.
   PubMedGoogle Scholar
• Hung MJ, Kuo LT, Cherng WJ. Amphetamine-related acute myocardial infarction due to coronary artery spasm. Int J Clin Pract. 2003;57(1):62–64.
   PubMed Web of Science ®Google Scholar
• Lam D, Goldschlager N. Myocardial injury associated with polysubstance abuse. Am Heart J. 1988;115(3):675–680.
   PubMed Web of Science ®Google Scholar
• Lan LWR, Yeh HI, Hou CJY, et al. Acute thrombosis of double major coronary arteries associated with amphetamine abuse. Acta Cardiol Sin. 2007;23(4):268–272.
   Web of Science ®Google Scholar
• Liakoni E, Dolder PC, Rentsch K, et al. Acute health problems due to recreational drug use in patients presenting to an urban emergency department in Switzerland. Swiss Med Wkly. 2015;145:w14166.
   PubMed Web of Science ®Google Scholar
• Packe GE, Garton MJ, Jennings K. Acute myocardial infarction caused by intravenous amphetamine abuse. Br Heart J. 1990;64(1):23–24.
   PubMedGoogle Scholar
• Ragland AS, Ismail Y, Arsura EL. Myocardial infarction after amphetamine use. Am Heart J. 1993;125(1):247–249.
   PubMed Web of Science ®Google Scholar
• Sinha A, Lewis O, Kumar R, et al. Amphetamine abuse related acute myocardial infarction. Case Rep Cardiol. 2016;2016:7967851.
   PubMedGoogle Scholar
• Smedra A, Szustowski S, Berent J. Amphetamine-related myocardial infarction in a 42-year old man. Archiwum Medycyny Sadowej i Kryminologii. 2015;65(3):173–181.
   PubMedGoogle Scholar
• Vichairuangthum K. Acute myocardial infarction with left main thromboses in a young amphetamine addict. Arch Med Sci Atheroscler Dis. 2020;5:e45–e48.
   PubMedGoogle Scholar
• Waksman J, Taylor RN, Bodor GS, et al. Acute myocardial infarction associated with amphetamine use. Mayo Clin Proc. 2001;76(3):323–326.
   PubMed Web of Science ®Google Scholar
• Azarpira N, Pourjafar M, Delavar-Kasmai H. Concurrent myocardial and cerebral infarctions after crystal methamphetamine use. Neurosurg Q. 2015;25(2):286–287.
   Google Scholar
• Chen JP. Methamphetamine-associated acute myocardial infarction and cardiogenic shock with normal coronary arteries: refractory global coronary microvascular spasm. J Invasive Cardiol. 2007;19(4):E89–E92.
   PubMedGoogle Scholar
• Farnsworth TL, Brugger CH, Malters P. Myocardial infarction after intranasal methamphetamine. Am J Health Syst Pharm. 1997;54(5):586–587.
   PubMed Web of Science ®Google Scholar
• Furst SR, Fallon SP, Reznik GN, et al. Myocardial infarction after inhalation of methamphetamine. N Engl J Med. 1990;323(16):1147–1148.
   PubMed Web of Science ®Google Scholar
• Guharoy R, Medicis J, Chol S, et al. Methamphetamine overdose: experience with six cases. Vet Human Toxicol. 1999;41(1):28–30.
   PubMedGoogle Scholar
• Hong R, Matsuyama E, Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA. 1991;265(9):1152–1154.
   PubMed Web of Science ®Google Scholar
• Huang MC, Yang SY, Lin SK, et al. Risk of cardiovascular diseases and stroke events in methamphetamine users: a 10-year follow-up study. J Clin Psychiatry. 2016;77(10):1396–1403.
   PubMed Web of Science ®Google Scholar
• Isoardi KZ, Ayles SF, Harris K, et al. Methamphetamine presentations to an emergency department: management and complications. Emerg Med Australas. 2019;31(4):593–599.
   PubMed Web of Science ®Google Scholar
• Khaheshi I, Mahjoob MP, Esmaeeli S, et al. Simultaneous thrombosis of the left anterior descending artery and the right coronary artery in a 34-year-old crystal methamphetamine abuser. Korean Circ J. 2015;45(2):158–160.
   PubMed Web of Science ®Google Scholar
• Turnipseed SD, Richards JR, Kirk JD, et al. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med. 2003;24(4):369–373.
   PubMed Web of Science ®Google Scholar
• Watts DJ, McCollester L. Methamphetamine-induced myocardial infarction with elevated troponin I. Am J Emerg Med. 2006;24(1):132–134.
   PubMed Web of Science ®Google Scholar
• Wijetunga M, Bhan R, Lindsay J, et al. Acute coronary syndrome and crystal methamphetamine use: a case series. Hawaii Med J. 2004;63(1):8–13.
   PubMedGoogle Scholar
• Hoggett K, McCoubrie D, Fatovich DM. Ecstasy-induced acute coronary syndrome: something to rave about. Emerg Med Australas. 2012;24(3):339–342.
   PubMed Web of Science ®Google Scholar
• Hanan Israelit S, Strizevsky A, Raviv B. ST elevation myocardial infarction in a young patient after ingestion of caffeinated energy drink and ecstasy. World J Emerg Med. 2012;3(4):305–307.
   PubMedGoogle Scholar
• Kafle P, Shrestha B, Mandal A, et al. Ecstasy induced acute systolic heart failure and Non-Ischemic cardiomyopathy in a young female: a rare case report and literature review. J Community Hosp Intern Med Perspect. 2019;9(4):336–339.
   PubMed Web of Science ®Google Scholar
• Lai TI, Hwang JJ, Fang CC, et al. Methylene 3, 4 dioxymethamphetamine-induced acute myocardial infarction. Ann Emerg Med. 2003;42(6):759–762.
   PubMed Web of Science ®Google Scholar
• Papachristidis A, Baghai M, Patel R, et al. Aortic thrombus causing myocardial infarction after recreational MDMA use. Eur Heart J Cardiovasc Imaging. 2016;17(10):1187.
   PubMed Web of Science ®Google Scholar
• Qasim A, Townend J, Davies MK. Ecstasy induced acute myocardial infarction. Heart. 2001;85(6):E10.
   PubMed Web of Science ®Google Scholar
• Sadeghian S, Darvish S, Shahbazi S, et al. Two ecstasy-induced myocardial infarctions during a three month period in a young man. Arch Iran Med. 2007;10(3):409–412.
   PubMed Web of Science ®Google Scholar
• Sarıçopur A, Dursunoğlu D, Şanlıalp M, et al. Subacute myocardial infarction due to long-term paint thinner and ecstasy abuse. Anatol J Cardiol. 2015;15(2):167–168.
   PubMed Web of Science ®Google Scholar
• Veenstra J, van der Wieken LR, Schuilenburg RM. Myocardial infarct following use of amphetamine derivatives. Ned Tijdschr Geneeskd. 1990;134(23):1150–1151.
   PubMedGoogle Scholar
• Hondebrink L, Nugteren-van Lonkhuyzen JJ, Rietjens SJ, et al. Fatalities, cerebral hemorrhage, and severe cardiovascular toxicity after exposure to the new psychoactive substance 4-Fluoroamphetamine: a prospective cohort study. Ann Emerg Med. 2018;71(3):294–305.
   PubMed Web of Science ®Google Scholar
• Gokdemir MT, Giden R. Acute inferior myocardial infarction associated with the ingestion of captagon pills: a case report. Turk J Emerg Med. 2019;19(2):79–82.
   PubMed Web of Science ®Google Scholar
• Ulucay A, Arpacik Kargi C, Aksoy MF. Acute myocardial infarction associated with captagon use. Anatol J Cardiol. 2012;12(2):182–185.
   Web of Science ®Google Scholar
• Al-Motarreb A, Briancon S, Al-Jaber N, et al. Khat chewing is a risk factor for acute myocardial infarction: a case-control study. Br J Clin Pharmacol. 2005;59(5):574–581.
   PubMed Web of Science ®Google Scholar
• Alkadi HO, Noman MA, Al-Thobhani AK, et al. Clinical and experimental evaluation of the effect of khat-induced myocardial infarction. Saudi Med J. 2002;23(10):1195–1198.
   PubMed Web of Science ®Google Scholar
• Croles FN, Brasse BP, Duisenberg-van Essenberg M, et al. Connection between hypertension and myocardial infarction and chewing of khat leaves. Nederlands Tijdschrift Voor Geneeskunde. 2009;153(1-2):38–43.
   PubMedGoogle Scholar
• Hussen AA, Hussien FM, Yusuf N, et al. Case report: khat chewing and acute myocardial infarction in two young men without underlying risk factors. Am J Trop Med Hyg. 2021;105(4):890–895.
   PubMed Web of Science ®Google Scholar
• Saha S, Dollery C. Severe ischaemic cardiomyopathy associated with khat chewing. J R Soc Med. 2006;99(6):316–318.
   PubMed Web of Science ®Google Scholar
• Al-Kebsi MM, Al-Motarreb A, Al-Wather N, et al. Characteristics and risk factors of yemeni patients presenting with myocardial infarction with nonobstructive coronary arteries (MINOCA). Heart Views. 2021;22(4):235–239.
   PubMedGoogle Scholar
• Bentur Y, Bloom-Krasik A, Raikhlin-Eisenkraft B. Illicit cathinone (“hagigat”) poisoning. Clin Toxicol. 2008;46(3):206–210.
   PubMed Web of Science ®Google Scholar
• Janiszewski M, Strojek M, Syska-Suminska J, et al. ST elevation myocardial infarction in a 26-year-old man after the use of mephedrone. Kardiol Pol. 2015;73(7):567.
   PubMed Web of Science ®Google Scholar
• Cherry SV, Rodriguez YF. Synthetic stimulant reaching epidemic proportions: flakka-induced ST-elevation myocardial infarction with intracardiac thrombi. J Cardiothorac Vasc Anesth. 2017;31(1):e13–e14.
   PubMedGoogle Scholar
• Ma I, Genet T, Clementy N, et al. Outcomes in patients with acute myocardial infarction and history of illicit drug use: a French nationwide analysis. Eur Heart J Acute Cardiovasc Care. 2021;10(9):1027–1037.
   PubMed Web of Science ®Google Scholar
• Gupta N, Washam JB, Mountantonakis SE, et al. Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the national cardiovascular data registry). Am J Cardiol. 2014;113(5):749–756.
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. European drug report 2022: trends and developments. Luxembourg: Publications Office of the European Union; 2022.
   Google Scholar
• Pineda J, Marin F, Roldan V, et al. Premature myocardial infarction: clinical profile and angiographic findings. Int J Cardiol. 2008;126(1):127–129.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Lewis CE, Schreiner PJ, et al. The coronary artery risk development in young adults (CARDIA) study. J Am Coll Cardiol. 2021;78(3):260–277.
   PubMed Web of Science ®Google Scholar
• Gulati A, Mathew C, Calton R. Young hearts go ischemic too. J Assoc Phys India. 2018;66(9):58–61.
   PubMedGoogle Scholar
• Esteban MR, Montero SM, Sanchez JJ, et al. Acute coronary syndrome in the young: clinical characteristics, risk factors and prognosis. Open Cardiovasc Med J. 2014;8:61–67.
   PubMedGoogle Scholar